REGULATORY EXPERTISE BUILT A PLATFORM FOR GROWTH

OUR TRACK RECORD | A GLOBAL NETWORK

This biotech’s lead product was fast approaching regulatory submission; it needed a COO who could navigate a uniquely complex path to approval. Commercial success depended on strong, scientifically proven health claims. The pioneering nature of the product meant that nobody in the UK or EU had the skills proven to overcome the regulatory hurdles. We presented a shortlist in just six weeks. The CEO faced a tough choice between two outstanding COO candidates. The successful individual had an unusual background: a smaller biotech hadn’t seemed possible to them before. But the fit was perfect and results proved it. Inside 18 months the new COO had helped seal a European-first approval, against a backdrop of 99% failure for all approvals under this directive. The COO is now a Board Director. The company now has licensing deals across the US and Europe.